US Patent 12,440,495 — assignment history and current owner

US 12,440,495 · Application 18/383,992

Combination Therapy For Treatment Of Myeloproliferative Neoplasms

Who owns US Patent 12,440,495?

US12440495 ("Combination Therapy For Treatment Of Myeloproliferative Neoplasms") — current assignee: INCYTE CORPORATION. Status: Active, estimated expiration June 2, 2041. 1 recorded USPTO assignment.

Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 12,440,495 is INCYTE CORPORATION. Based on the most recent ownership transfer record (recorded 2023-10-31).

Patent title
Combination Therapy For Treatment Of Myeloproliferative Neoplasms
Application number
18/383,992
Apparent operating assignee
INCYTE CORPORATION
Patent status
Active, estimated expiration June 2, 2041
Recorded assignments
1

Recorded assignment history

ExecutedRecordedConveyanceAssignor(s)Assignee(s)Reel/frame
Mar 23, 2022Oct 31, 2023Ownership TransferSTUBBS, MATTHEW; LIU, PHILLIP C.INCYTE CORPORATION65399/261

Scrolls sideways on narrow screens

Chain of title

In 2023, STUBBS, MATTHEW; LIU, PHILLIP C. assigned the patent to INCYTE CORPORATION.

Apparent recorded rights summary — disclaimer

This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.

Ownership settled? Give your AI the file.

Application 18/383,992 · US 12,440,495

The recorded chain of title is one part of the record. PatentReply compiles the rest of US 12,440,495, from the claims as filed to the last action, for Claude, ChatGPT, Grok, or another supported AI client.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.